• Home

  • Documents

  • PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism...
52

PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 2: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 3: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 4: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 5: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 6: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 7: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 8: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 9: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 10: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 11: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 12: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 13: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 14: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 15: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

>

Page 16: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 17: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 18: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 19: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 20: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 21: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 22: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 23: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 24: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 25: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 26: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 27: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 28: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 29: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 30: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 31: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 32: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 33: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 34: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 35: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 36: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 37: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 38: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 39: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 40: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 41: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 42: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 43: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade

•

•

•

•

•

•

•

•

•

•

•

Page 44: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 45: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 46: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade

•

•

•

•

•

•

•

•

Page 47: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 48: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 49: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 50: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 51: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade
Page 52: PowerPoint-Präsentation · CHEST 2016; 1. In patients with proximal DVT or pulmonary embolism (PE), we recommend long-term (3 months) anticoagulant therapy over no such therapy (Grade

Safety and Efficacy of Direct Oral Anticoagulant Therapy

Safety and Efficacy of Direct Oral Anticoagulant Therapy

Documents
Guide for Patients Undergoing Anticoagulant Therapy Study Guide

Guide for Patients Undergoing Anticoagulant Therapy Study Guide

Documents
Combined anticoagulant and antiplatelet therapy is

Combined anticoagulant and antiplatelet therapy is

Documents
E.9 Thrombolytic therapy (DVT) - National Center … Venous thromboembolic diseases Clinical evidence tables E.9 Thrombolytic therapy (DVT) What is the effectiveness of thrombolytic

E.9 Thrombolytic therapy (DVT) - National Center … Venous thromboembolic diseases Clinical evidence tables E.9 Thrombolytic therapy (DVT) What is the effectiveness of thrombolytic

Documents
Outpatient anticoagulant therapy

Outpatient anticoagulant therapy

Documents
Anticoagulant therapy

Anticoagulant therapy

Documents
Anticoagulation Update: DOACs, VTE Guidelines, “Bridging ... · In patients with DVT of the leg or PE and no cancer, as long‐term (first 3 months) anticoagulant therapy, we suggest

Anticoagulation Update: DOACs, VTE Guidelines, “Bridging ... · In patients with DVT of the leg or PE and no cancer, as long‐term (first 3 months) anticoagulant therapy, we suggest

Documents
Anticoagulant therapy in RPL

Anticoagulant therapy in RPL

Documents
Oral Anticoagulant Therapy in Atrial Fibrillation Patients

Oral Anticoagulant Therapy in Atrial Fibrillation Patients

Documents
Management of Oral Anticoagulant Therapy Principles & Practice

Management of Oral Anticoagulant Therapy Principles & Practice

Documents
Secondary Prevention after ACS: Focused on Anticoagulant Therapy

Secondary Prevention after ACS: Focused on Anticoagulant Therapy

Health & Medicine
How to Manage Anticoagulant Therapy · How to Manage Anticoagulant Therapy ... Egbe, A.C. et al. J Am Coll Cardiol. 2015; 66(21):2285–94 . Bioprosthetic Valve Failure Subclinical

How to Manage Anticoagulant Therapy · How to Manage Anticoagulant Therapy ... Egbe, A.C. et al. J Am Coll Cardiol. 2015; 66(21):2285–94 . Bioprosthetic Valve Failure Subclinical

Documents
ANTICOAGULANT THERAPY FOR PULMONARY HYPERTENSION …

ANTICOAGULANT THERAPY FOR PULMONARY HYPERTENSION …

Documents
Review Article Oral Anticoagulant Therapy in Patients ...downloads.hindawi.com/journals/tswj/2013/170576.pdf · Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is

Review Article Oral Anticoagulant Therapy in Patients ...downloads.hindawi.com/journals/tswj/2013/170576.pdf · Oral Anticoagulant Therapy in Patients Receiving Haemodialysis: Is

Documents
Fatal recurrent VTE after anticoagulant treatment for ...unprovoked VTE at baseline (PE/DVT), case-fatality rate of recurrent VTE during follow-up after anticoagulant discontinuation

Fatal recurrent VTE after anticoagulant treatment for ...unprovoked VTE at baseline (PE/DVT), case-fatality rate of recurrent VTE during follow-up after anticoagulant discontinuation

Documents
Research Article Usefulness of Anticoagulant …downloads.hindawi.com/journals/bmri/2014/254187.pdfResearch Article Usefulness of Anticoagulant Therapy in the Prevention of Embolic

Research Article Usefulness of Anticoagulant …downloads.hindawi.com/journals/bmri/2014/254187.pdfResearch Article Usefulness of Anticoagulant Therapy in the Prevention of Embolic

Documents
WARFARIN THERAPY Nicolas Novitzky. The Ideal Oral Anticoagulant Ideally, an oral anticoagulant would: Have high efficacy in reducing thromboembolic

WARFARIN THERAPY Nicolas Novitzky. The Ideal Oral Anticoagulant Ideally, an oral anticoagulant would: Have high efficacy in reducing thromboembolic

Documents
Anticoagulant Therapy in Acute Coronary Syndromes1 Anticoagulant Therapy in Acute Coronary Syndromes Robert P. Giugliano, MD, SM, FACC, FAHA Senior Investigator, TIMI Study Group Associate

Anticoagulant Therapy in Acute Coronary Syndromes1 Anticoagulant Therapy in Acute Coronary Syndromes Robert P. Giugliano, MD, SM, FACC, FAHA Senior Investigator, TIMI Study Group Associate

Documents
Telemedicine for Managing Patients on Oral Anticoagulant Therapy

Telemedicine for Managing Patients on Oral Anticoagulant Therapy

Documents
Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015

Warfarin Sodium (Anticoagulant) Therapy Training 03/10/2015

Documents
A Guide for Patients Prescribed Oral Anticoagulant Therapy A5 · 2016. 9. 30. · • Without oral anticoagulant therapy, roughly m in n l AF patients will suff er an AF-related

A Guide for Patients Prescribed Oral Anticoagulant Therapy A5 · 2016. 9. 30. · • Without oral anticoagulant therapy, roughly m in n l AF patients will suff er an AF-related

Documents
Management of Oral Anticoagulant Therapy

Management of Oral Anticoagulant Therapy

Documents
A Guide for Patients Prescribed Oral Anticoagulant Therapy · 2016-06-03 · having an AF-related stroke and it is essential to keep taking the anticoagulant therapy prescribed by

A Guide for Patients Prescribed Oral Anticoagulant Therapy · 2016-06-03 · having an AF-related stroke and it is essential to keep taking the anticoagulant therapy prescribed by

Documents
Management of anticoagulant therapy in pregnancy - Pascar · Management of anticoagulant therapy in pregnancy Prof Serigne abdou BA JOINT CONGRESS BETWEEN THE PAN-AFRICAN SOCIETY

Management of anticoagulant therapy in pregnancy - Pascar · Management of anticoagulant therapy in pregnancy Prof Serigne abdou BA JOINT CONGRESS BETWEEN THE PAN-AFRICAN SOCIETY

Documents
Oral Surgery in Patients on Anticoagulant Therapy

Oral Surgery in Patients on Anticoagulant Therapy

Education
#28 Anticoagulant Therapy

#28 Anticoagulant Therapy

Documents
University of Groningen Hemostasis and anticoagulant ... · Hemostasis and Anticoagulant Therapy in ... The underlying mechanisms include increased activation of platelets, reduced

University of Groningen Hemostasis and anticoagulant ... · Hemostasis and Anticoagulant Therapy in ... The underlying mechanisms include increased activation of platelets, reduced

Documents
ACS: Antiplatelet, Anticoagulant Therapy and Combinations .../media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Meetings/2015...ACS: Antiplatelet, Anticoagulant Therapy and Combinations

ACS: Antiplatelet, Anticoagulant Therapy and Combinations .../media/Non-Clinical/Files-PDFs-Excel-MS-Word-etc/Meetings/2015...ACS: Antiplatelet, Anticoagulant Therapy and Combinations

Documents
DRY FIX VALLEY TROUGHS€¦ · DS5 DVT F8.5 DVT F12 DVT F15 DVT G10 DVLPT H10 DVT H14 DVT H15 DVLPT S9 DVLPT SP10 DVT Double Pantile DVT Double Roman DVT Planum DVLPT Wolds DVT CREST

DRY FIX VALLEY TROUGHS€¦ · DS5 DVT F8.5 DVT F12 DVT F15 DVT G10 DVLPT H10 DVT H14 DVT H15 DVLPT S9 DVLPT SP10 DVT Double Pantile DVT Double Roman DVT Planum DVLPT Wolds DVT CREST

Documents
Implementing NPSA Requirements: Anticoagulant Therapy · 2020-03-01 · Medicines Use and Safety Implementing NPSA requirements: Anticoagulant therapy Vs2 – Jul11 (JN) 2 S P S Introduction

Implementing NPSA Requirements: Anticoagulant Therapy · 2020-03-01 · Medicines Use and Safety Implementing NPSA requirements: Anticoagulant therapy Vs2 – Jul11 (JN) 2 S P S Introduction

Documents